Citius Oncology CTOR
NASDAQ CTOR
$0.68 -0.02 (-2.51%)
As of: Oct 23, 2026 · 1:22 PM EDT

Citius Oncology (CTOR) Gross Profit (2025 - 2026)

Updated

Citius Oncology's Gross Profit was $1 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.1% from the prior quarter.

Analysis

Citius Oncology (CTOR) Gross Profit (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.34 Bn 1,099.92 Bn 19.71 Bn
2 Johnson & Johnson 634.44 Bn 554.30 Bn 17.30 Bn
3 AbbVie 506.53 Bn 479.65 Bn 12.70 Bn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn
5 Novartis Ag 291.71 Bn 255.70 Bn 11.24 Bn
6 Astrazeneca 265.06 Bn 238.74 Bn 12.86 Bn
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn
8 Gilead Sciences 195.32 Bn 169.52 Bn 6.22 Bn
9 Pfizer 171.12 Bn 117.76 Bn 10.94 Bn
10 Citius Oncology 73.57 Mn 43.15 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.34 Mn
Dec 31, 2025 3.15 Mn
API Access

Citius Oncology Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CTOR&period=max&api_key=YOUR_API_KEY